Peer-reviewed paper calls for an immediate stop to mRNA ‘vaccine’ use

The comprehensive study was also highly critical of the lack of scientific trials of the novel gene therapy prior to mass ‘vaccination’.

The new study titled, ‘mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign’ published on Cureus yesterday critically examined the safety, efficacy, and regulatory approval of COVID-19 mRNA vaccines, highlighting significant concerns with the methods, execution, and reporting of the pivotal trials that led to the Emergency Use Authorization (EUA) of the novel gene therapy in the US (and later New Zealand), marketed to the public as a ‘vaccine’.

The original trials for COVID-19 mRNA gene therapy did not adhere to established scientific standards for safety testing. Serious Adverse Events (SAEs) were significantly higher in the vaccine group, including death, cancer, cardiac events, and various disorders than in the non-vaccinated group, which contradicted health authorities’ claims of it being ‘safe and effective’.

The mRNA products were authorised rapidly without the typical testing period of 10-15 years for new vaccines. This expedited process bypassed many safety and toxicology protocols.

The numerous adverse events following vaccination that have been reported ‘raised concerns about the safety profile of the vaccines.’

Re-examination of Pfizer’s trial data also showed an increase in all-cause mortality in the ‘vaccine group’ compared to the placebo group.

The report said the mRNA gene therapy failed to induce mucosal immunity while increasing the risk of immune dysfunction with repeated booster doses. The authors also had concerns about the quality control of the vaccines, including potential batch variability and contamination issues.

The report called for a global moratorium on the use of COVID-19 mRNA vaccines until further safety and efficacy studies are conducted.

1/2 New peer-reviewed bombshell critique of the #mRNA shots👇
‘Moreover, the COVID-19 mRNA vaccines produced via Process 1 and evaluated in the trials were not the same products eventually distributed worldwide; all of the COVID-19 mRNA products released to the public were…

— Sonia Elijah (@sonia_elijah) January 25, 2024

2/2
The peer-reviewed study confirms what I reported on here 👇https://t.co/3f3EXkUAT5

— Sonia Elijah (@sonia_elijah) January 25, 2024